Abstract
Development of potent, selective and orally bioactive dipeptidyl Peptidase IV inhibitors as antihyperglycemic agents is challenging task due to potential side effects are associated with them. It may result from other prolyldipeptidases of DPP-4 include DPP-2, DPP-8 and DPP-9. To resolve the selectivity issue in different DPP enzymes hologram quantitative structure-activity relationship studies were carried out on a series of potent and selective DPP-4 ligands. To measure selectivity between two kinds of enzyme selectivity data of DPP-4 over DPP-2, DPP-8 and DPP-9 were calculated and best HQSAR models were generated with significant correlation coefficients. The statistical results of the three models showed the best prediction and fitness for the selectivity activities. Docking studies were carried out on conformationally rigid 3-azabicyclo [3.1.0] hexane derivatives which suggested the substitution pattern on P1 and P2 fragment. The finally QSAR model, along with the information obtained from contribution maps and docking studies should be useful for the design of novel DPP-4 ligands having improved selectivity without side effects.
Keywords: HQSAR, 3-azabicyclo [3.1.0] hexane derivatives, Fragment based design, Selectivity, DPP-4 inhibitors, Docking.
Letters in Drug Design & Discovery
Title:Fragment Based HQSAR Modeling and Docking Analysis of Conformationally Rigid 3-azabicyclo [3.1.0] Hexane Derivatives to Design Selective DPP-4 Inhibitors
Volume: 11 Issue: 2
Author(s): Manjunath Ghate and Shailesh V. Jain
Affiliation:
Keywords: HQSAR, 3-azabicyclo [3.1.0] hexane derivatives, Fragment based design, Selectivity, DPP-4 inhibitors, Docking.
Abstract: Development of potent, selective and orally bioactive dipeptidyl Peptidase IV inhibitors as antihyperglycemic agents is challenging task due to potential side effects are associated with them. It may result from other prolyldipeptidases of DPP-4 include DPP-2, DPP-8 and DPP-9. To resolve the selectivity issue in different DPP enzymes hologram quantitative structure-activity relationship studies were carried out on a series of potent and selective DPP-4 ligands. To measure selectivity between two kinds of enzyme selectivity data of DPP-4 over DPP-2, DPP-8 and DPP-9 were calculated and best HQSAR models were generated with significant correlation coefficients. The statistical results of the three models showed the best prediction and fitness for the selectivity activities. Docking studies were carried out on conformationally rigid 3-azabicyclo [3.1.0] hexane derivatives which suggested the substitution pattern on P1 and P2 fragment. The finally QSAR model, along with the information obtained from contribution maps and docking studies should be useful for the design of novel DPP-4 ligands having improved selectivity without side effects.
Export Options
About this article
Cite this article as:
Ghate Manjunath and V. Jain Shailesh, Fragment Based HQSAR Modeling and Docking Analysis of Conformationally Rigid 3-azabicyclo [3.1.0] Hexane Derivatives to Design Selective DPP-4 Inhibitors, Letters in Drug Design & Discovery 2014; 11 (2) . https://dx.doi.org/10.2174/15701808113109990051
DOI https://dx.doi.org/10.2174/15701808113109990051 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Indications for Surgery and Operative Techniques in Infective Endocarditis in the Present Day
Infectious Disorders - Drug Targets The Potential Dual Effects of Anesthetic Isoflurane on Aβ-Induced Apoptosis
Current Alzheimer Research Dietary Management of Gestational Diabetes Mellitus
Current Nutrition & Food Science Saccharomyces cerevisiae β-Carbonic Anhydrase: Inhibition and Activation Studies
Current Pharmaceutical Design New Developments in Pichia pastoris Expression System, Review and Update
Current Pharmaceutical Biotechnology Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer
Current Medicinal Chemistry Role of Autophagy in Chronic Liver Inflammation and Fibrosis
Current Protein & Peptide Science An Overview on Protein Fold Classification via Machine Learning Approach
Current Proteomics Subject Index to Volume 4
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Contribution of Canalicular Glutathione Efflux to Bile Formation. From Cholestasis Associated Alterations to Pharmacological Intervention to Modify Bile Flow
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Affinity Selection-Mass Spectrometry and its Emerging Application to the High Throughput Screening of G Protein-Coupled Receptors
Combinatorial Chemistry & High Throughput Screening Chronic Granulomatous Disease in Childhood
Current Pediatric Reviews Translational Insight Into Polycystic Ovary Syndrome (PCOS) From Female Monkeys with PCOS-like Traits
Current Pharmaceutical Design Is There A Relationship Between Insulin Resistance and Frailty Syndrome?
Current Pharmaceutical Design Conantokins: Peptide Antagonists of NMDA Receptors
Current Medicinal Chemistry Macrophage Inflammatory Protein 1 and CCR5 as Attractive Therapeutic Targets for HIV Infection
Recent Patents on Anti-Infective Drug Discovery Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Current Alzheimer Research Stem Cells in Mammary Health and Milk Production
Current Stem Cell Research & Therapy Reciprocity in Microbiome and Immune System Interactions and its Implications in Disease and Health
Inflammation & Allergy - Drug Targets (Discontinued) Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs Against COVID-19
Mini-Reviews in Medicinal Chemistry